Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alphaIIb/beta3) receptor-directed platelet inhibition.

Li, Y F; Spencer, F A; Becker, R C

Li, Y F; Spencer, F A; Becker, R C.

Affiliation

Li YF; Cardiovascular Thrombosis Research Center, Laboratory for Vascular Biology Research, University of Massachusetts Medical School, Worcester, MA 01655, USA.

Am Heart J ; 142(2): 204-10, 2001 Aug.

Article in En | MEDLINE | ID: mdl-11479455

Subject(s)

Fibrinogen/pharmacology; Peptides/pharmacology; Platelet Aggregation Inhibitors/pharmacology; Platelet Aggregation/drug effects; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Platelet Transfusion; Tyrosine/pharmacology; Adult; Cells, Cultured/drug effects; Dose-Response Relationship, Drug; Eptifibatide; Fibrinogen/therapeutic use; Humans; Middle Aged; Peptides/administration & dosage; Platelet Aggregation Inhibitors/administration & dosage; Reference Values; Tirofiban; Tyrosine/administration & dosage; Tyrosine/analogs & derivatives

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Tyrosine / Fibrinogen / Platelet Aggregation Inhibitors / Platelet Aggregation / Platelet Transfusion / Platelet Glycoprotein GPIIb-IIIa Complex Limits: Adult / Humans / Middle aged Language: En Journal: Am Heart J Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links